The results of a new study have once more confirmed the link between early balding and an increased risk of prostate cancer, this time in a test group of African American males. The focus on this ethnic group was due to the fact that African American males have a high likelihood of prostate cancer compared to other races.
Published in medical journal Cancer Epidemiology, Biomarkers & Prevention, results showed that noticeable hair loss of all kinds is associated with a 65% increase in the risk of prostate cancer for all African American men. Researchers also established that age and the type of balding can also affect the participants’ prostate cancer risk.
Balding: Not Just Skin Deep
In terms of the type of baldness, men with frontal hair loss (a receding hairline) were twice as likely to be diagnosed with advanced prostate cancer. It was also noted that bald men who were diagnosed with cancer before the age of 60 had a six fold increase in high stage prostate cancer.
So, what should African American men take from these results? Early onset baldness appears to be a risk factor for early onset prostate cancer in African American men, and as such if you’re a member of this ethnic group regular prostate examinations are a good idea, especially if you notice thinning hair from a relatively early age.
A Step In The Right Direction
More research is needed to understand why going bald younger seems to be linked with an increased likelihood of this type of cancer, and hopefully when more is known men at high risk of developing cancer can be identified and treated before the cancer develops.
Whilst we are unable to help with cancer and hair loss from cancer treatment, we can help with the other types of hair loss, including male pattern balding which affects 95% of men dealing with hair loss. A receding hairline can be effectively treated with a bespoke hair loss treatment programme tailored to your needs by a hair loss specialist.
How We Can Help
The most effective way to halt your rate of hair loss and regrow hair in thinning areas involves a combination of the only two clinically proven for hair loss medications. The first of these, Propecia, works by blocking the powerful androgen DHT, which causes hair follicles atop the scalp to shrink and consequentially produce weaker hair, and after an extended period of time, no hair at all (at which point hair loss cannot be treated medically).
A second medication, minoxidil, is applied directly to the thinning areas, and whilst specialists are unsure why it is consistently so effective for hair loss, it appears to stimulate the growth of new hair. Unlike Propecia, minoxidil can be varied in strength to suit the individual needs of each patient, with a maximum daily dose of up to 18% including a high strength minoxidil cream: much higher than the 5% available from the chemist. By combining these two medications with a variety of hair growth boosters, a comprehensive treatment programme is formed that gives you the best chance of regrowing hair.
The Belgravia Centre—————————————————————————————————–
The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. We offer clinically proven treatments for hair loss, as part of comprehensive treatment programmes offered by our hair loss specialists. Our in-house pharmacies produce high-strength medications for hair loss that contain medically proven ingredients and are available at no other clinic worldwide. Treatment programmes are available by visiting the centres or for home-use, anywhere in the UK or the rest of the world. View our hair loss success stories, which are the largest collection of such success stories in the world and demonstrate the levels of hair regrowth that so many of Belgravia’s patients achieve. You can also phone 0800 077 6666 for our hair loss helpline or to arrange a free consultation.